Stock Events

Stock Events

Noveris Health Sciences 

$0.8000
58
+$0.07+9.59% Friday 20:00

Statistics

Day High
0.8
Day Low
0.8
52W High
2.04
52W Low
0.029
Volume
1,000
Avg. Volume
411
Mkt Cap
46.84M
P/E Ratio
0.62
Dividend Yield
-
Dividend
-

Earnings

17AugExpected
Q2 2024
Q3 2024
Q4 2024
Q2 2025
Q3 2025
Q1 2026
Next
999
333
-333
-999
Expected EPS
N/A
Actual EPS
N/A

Financials

-Profit Margin
Profitable
2020
2021
2022
2023
2024
2025
0Revenue
2.14MNet Income

People Also Follow

This list is based on the watchlists of people on Stock Events who follow MYCOF. It's not an investment recommendation.
Vanguard S&P 500 Index
10
VFV.TO
Microsoft
7
MSFT
NVIDIA
7
NVDA
Bitcoin
7
BTC.CRYPTO

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
Compass Pathways
CMPS
Mkt Cap1.86B
Compass Pathways focuses on psilocybin therapy for mental health disorders, directly competing in the psychedelic medicine space with Mydecine Innovations.
AtaiBeckley
ATAI
Mkt Cap2.69B
ATAI Life Sciences is a biotech company working on mental health treatments using psychedelics, overlapping with Mydecine's focus areas.
GH Research
GHRS
Mkt Cap2.02B
GH Research focuses on developing 5-MeO-DMT therapies for depression, competing in the psychedelic treatment market.
Revive Therapeutics
RVVTF
Mkt Cap9.15M
Revive Therapeutics is exploring the use of psychedelics for medical treatments, including areas Mydecine Innovations is involved in.
Nuveen Municipal Income
NUMI
Mkt Cap0
Numinus Wellness is engaged in psychedelic production and therapy, directly competing with Mydecine's business model.
TripAdvisor
TRIP
Mkt Cap1.26B
Red Light Holland is involved in the production and sale of recreational truffles, indirectly competing by promoting psychedelic acceptance.

About

Mydecine Innovations Group Inc., a biotechnology company, engages in the development and commercialization of psilocybin products for treating mental health problems. The company primarily focuses on treating smoking cessation. Its lead product drug candidates include MYCO-001, MYCO-002, MYCO003, and MYCO-004. Mydecine Innovations Group Inc. has a partnership with Applied Pharmaceutical Innovation for pharmaceutical drug discovery, research, and development on empathogenic and entactogenic compounds. The company was formerly known as NewLeaf Brands Inc. and changed its name to Mydecine Innovations Group Inc. in June 2020. Mydecine Innovations Group Inc. was incorporated in 2013 and is headquartered in Vancouver, Canada.
Show more...
CEO
Jason Birmingham
Employees
3
Country
Canada
ISIN
CA66990B1085
WKN
000A42208

Listings

STU
DE
0NF1.STU
CN
CA
NVRS.CN
MU
DE
0NFA.MU
STU
DE
0NFA.STU

0 Comments

Share your thoughts

FAQ

What is Noveris Health Sciences stock price today?▼
The current price of MYCOF is $0.80 USD — it has increased by +9.59% in the past 24 hours. Watch Noveris Health Sciences stock price performance more closely on the chart.
What is Noveris Health Sciences stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on OTC Link exchange Noveris Health Sciences stocks are traded under the ticker MYCOF.
Is Noveris Health Sciences stock price growing?▼
MYCOF stock has risen by +9.59% compared to the previous week, the month change is a -27.27% fall, over the last year Noveris Health Sciences has showed a +166.67% increase.
What is Noveris Health Sciences market cap?▼
Today Noveris Health Sciences has the market capitalization of 46.84M
What is Noveris Health Sciences revenue for the last year?▼
Noveris Health Sciences revenue for the last year amounts to 0 USD.
What is Noveris Health Sciences net income for the last year?▼
MYCOF net income for the last year is 2.14M USD.
How many employees does Noveris Health Sciences have?▼
As of August 18, 2026, the company has 3 employees.
In which sector is Noveris Health Sciences located?▼
Noveris Health Sciences operates in the Health & Wellness sector.
When did Noveris Health Sciences complete a stock split?▼
The last stock split for Noveris Health Sciences was on October 21, 2025 with a ratio of 1:50.
Where is Noveris Health Sciences headquartered?▼
Noveris Health Sciences is headquartered in Vancouver, Canada.